Medicare Part B Oral Chemotherapy Demo Limited To Approved Indications
Executive Summary
Reimbursement for oral chemotherapy products under a Medicare Part B demonstration project will be limited to FDA-approved indications, the Centers for Medicare & Medicaid Services' proposed criteria say